⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
PHGE News
BiomX Inc.
BiomX Announces $3.0 Million Private Placement
globenewswire.com
PHGE
BiomX Announces Discontinuation of Phase 2b BX004 Trial Following Internal Review
globenewswire.com
PHGE
BiomX Provides Update on BX004 Phase 2b Trial in Cystic Fibrosis
globenewswire.com
PHGE
BiomX Inc. Announces 1-for-19 Reverse Stock Split
globenewswire.com
PHGE
BiomX Reports Third Quarter 2025 Financial Results and Provides Program Updates
globenewswire.com
PHGE
BiomX to Report Third Quarter 2025 Financial Results and Program Updates on November 12, 2025
globenewswire.com
PHGE
BiomX Announces Positive FDA Feedback Supporting Next-Generation Phage Cocktail Program for Diabetic Foot Infections
globenewswire.com
PHGE
BiomX Provides a Program Update and Announces New FDA Feedback Potentially Expanding BX004 Development Pathways
globenewswire.com
PHGE